Cargando…

Prognostic value of routinely available data in patients with stable coronary heart disease. A 10-year follow-up of patients sampled at random times during their disease course

OBJECTIVE: To characterise the long-term prognosis of patients with stable coronary artery heart disease by means of ‘standard predictors’ defined as demographic, clinical and biochemical quantities routinely available in general practices and ascertained at an interview not prompted by renewed card...

Descripción completa

Detalles Bibliográficos
Autores principales:	Winkel, Per, Jakobsen, Janus Christian, Hilden, Jørgen, Jensen, Gorm, Kjøller, Erik, Sajadieh, Ahmad, Kastrup, Jens, Kolmos, Hans Jørn, Larsson, Anders, Ärnlöv, Johan, Gluud, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Coronary Artery Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135459/ https://www.ncbi.nlm.nih.gov/pubmed/30228904 http://dx.doi.org/10.1136/openhrt-2018-000808

Ejemplares similares

Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial
por: Winkel, Per, et al.
Publicado: (2017)

Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial
por: Winkel, Per, et al.
Publicado: (2020)

10‐Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy
por: Carlsson, Axel C., et al.
Publicado: (2018)

Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease
por: Schroder, Jakob, et al.
Publicado: (2020)

Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up—A CLARICOR Trial Sub-Study
por: Nilsson, Erik, et al.
Publicado: (2020)

Coronary wave intensity patterns in stable coronary artery disease: influence of stenosis severity and collateral circulation
por: deMarchi, Stefano F, et al.
Publicado: (2019)

Cost-effectiveness of cardiovascular imaging for stable coronary heart disease
por: Walker, Simon, et al.
Publicado: (2021)

Risk prediction in stable cardiovascular disease using a high-sensitivity cardiac troponin T single biomarker strategy compared to the ESC-SCORE
por: Biener, Moritz, et al.
Publicado: (2018)

Using electronic health records to predict costs and outcomes in stable coronary artery disease
por: Asaria, Miqdad, et al.
Publicado: (2016)

Risk prediction score for clinical outcome in atrial fibrillation and stable coronary artery disease
por: Ishii, Masanobu, et al.
Publicado: (2023)

Long-term impact of baseline anaemia on clinical outcomes following percutaneous coronary intervention in stable angina
por: Davidsen, Line, et al.
Publicado: (2020)

Assessment of left and right atrial geometrical changes in patients with stable coronary artery disease: Left and right atrial strain and strain rate imaging study
por: khedr, Lamiaa, et al.
Publicado: (2018)

Difference in plaque characteristics of coronary culprit lesions in a cohort of Egyptian patients presented with acute coronary syndrome and stable coronary artery disease: An optical coherence tomography study
por: ElFaramawy, Amr, et al.
Publicado: (2018)

Role of ivabradine in management of stable angina in patients with different clinical profiles
por: Kaski, Juan Carlos, et al.
Publicado: (2018)

Clinical determinants of plasma cardiac biomarkers in patients with stable chest pain
por: Bing, Rong, et al.
Publicado: (2019)

Impact on stable chest pain pathways of CT fractional flow reserve
por: O'Leary, Rachel A, et al.
Publicado: (2023)

Sex differences in mortality in stable patients undergoing vasodilator stress cardiovascular magnetic resonance
por: Miñana, Gema, et al.
Publicado: (2021)

Power estimations for non-primary outcomes in randomised clinical trials
por: Jakobsen, Janus Christian, et al.
Publicado: (2019)

Assessing the severity of cardiovascular disease in 213 088 patients with coronary heart disease: a retrospective cohort study
por: Zghebi, Salwa S, et al.
Publicado: (2021)

Why percutaneous revascularisation might not reduce the risk of myocardial infarction and mortality in patients with stable CAD?
por: Benenati, Stefano, et al.
Publicado: (2023)

Single-centre cohort study of gender influence in coronary CT angiography in patients with a low to intermediate pretest probability of coronary heart disease
por: Nørgaard, Kirsten Schou, et al.
Publicado: (2015)

Randomised trial of stable chest pain investigation: 3-year clinical and quality of life results from CE-MARC 2
por: Everett, Colin C., et al.
Publicado: (2023)

Three‐year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus‐eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub‐study
por: Kerkmeijer, Laura S.M., et al.
Publicado: (2020)

Comparative evaluation of coronary disease burden: bicuspid valve disease is not atheroprotective
por: Dolmaci, Onur Baris, et al.
Publicado: (2021)

A zero coronary artery calcium score in patients with stable chest pain is associated with a good prognosis, despite risk of non-calcified plaques
por: Wang, Xue, et al.
Publicado: (2019)

Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection
por: Loffi, Marco, et al.
Publicado: (2020)

Long-term outcomes among stable post-acute myocardial infarction patients living in rural versus urban areas: insights from the prospective, observational TIGRIS registry
por: Nicolau, Jose Carlos, et al.
Publicado: (2023)

Cardiovascular status after Kawasaki disease in the UK
por: Shah, V, et al.
Publicado: (2015)

Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)

Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual‐therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)

Danish study of Non-Invasive Testing in Coronary Artery Disease 3 (Dan-NICAD 3): study design of a controlled study on optimal diagnostic strategy
por: Winther, Simon, et al.
Publicado: (2023)

Patient delay and benefit of timely reperfusion in ST-segment elevation myocardial infarction
por: Scholz, Karl Heinrich, et al.
Publicado: (2021)

Peripheral artery disease and outcomes in patients with acute myocardial infarction
por: Attar, Rubina, et al.
Publicado: (2019)

Influence of health-related quality of life on time from symptom onset to hospital arrival and the risk of readmission in patients with myocardial infarction
por: Henriksson, Catrin, et al.
Publicado: (2014)

Duration of myocardial early systolic lengthening for diagnosis of coronary artery disease
por: Minamisawa, Masatoshi, et al.
Publicado: (2018)

Comorbidity phenotypes and risk of mortality in patients with ischaemic heart disease in the UK
por: Crowe, Francesca, et al.
Publicado: (2020)

Lifestyle modification in older versus younger patients with coronary artery disease
por: Jepma, Patricia, et al.
Publicado: (2020)

Intensified lipid-lowering treatment with alirocumab in patients with coronary heart disease
por: Steffens, Daniel, et al.
Publicado: (2021)

Physical exercise and quantitative lower limb collateral function
por: Stoller, Michael, et al.
Publicado: (2016)

Increased coronary heart disease and stroke hospitalisations from ambient temperatures in Ontario
por: Bai, Li, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ghirfflq4fcpap699tqeuve2q1